NationalCenter_Adherence of cell-free DNA noninvasive prenatal screens to ACMG recommendations
Product Description:
Purpose: Noninvasive prenatal screening (NIPS) for fetal aneuploidy via cell-free DNA has been commercially available in the United States since 2011. In 2016, the American College of Medical Genetics and Genomics (ACMG) issued a position statement with specific recommendations for testing laboratories. We sought to evaluate adherence to these recommendations.
Keyword(s):
prenatal testing
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Professionals
Alternative Format:
Electronic (disc, CD, 508 compliant web posting)
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A